BAY-593
Based on 1 Customer Validation
BAY-593 is an orally active GGTase-I inhibitor. BAY-593 can block YAP1/TAZ signaling in animals and has antitumor activity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.94%
- CAS 番号: 2413020-56-9
- 分子式: C26H31F3N2O3
- 分子量:476.53
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
|
GGTase I |
BAY-593 (0.5 nM-10 μM; 72 h) inhibits the proliferation of HT-1080 and MDA-MB-231 cells with the IC50 values of 0.038 and 0.564 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Pharmacokinetic Analysis in HT-1080 xenograft mouse models[1]
| Route | Dose (mg/kg) | Schedule | T/Cvolume on day 9 | Cmax (μg/L) | 4 days AUC (mg·h/L) | 4 days AUCunbound (μg·h/L) |
| p.o. | 2.5 | BID | 0.44 | 100 | 2.6 | 37 |
| p.o. | 5 | QD | 0.43 | 76 | 2.8 | 39 |
| p.o. | 10 | Q2D | 0.069 | 350 | 5.4 | 76 |
| p.o. | 20 | Q4D | 0.063 | 2262 | 16.0 | 224 |
| p.o. | 5 | BID | 0.056 | 275 | 8.0 | 112 |
| p.o. | 10 | QD | 0.021 | 321 | 14.0 | 196 |